CHROMOGENIC MEDIA MARKET

INTRODUCTION

 Chromogenic media are a type of new media developed to improve identification of certain bacteria. These media utilize chromogens, which are colorless molecules that can be oxidized to colored compounds, that convert to different colors when degraded by different microbial enzymes.

The media were first developed primarily for the rapid detections of MRSA (Methicillin Resistant Staphylococcus aureus), an important drug resistant bacterium frequently occurring in hospitals and more recently in the general population.

Additional chromogenic media have been developed for a variety of important clinical isolates and pathogens, especially drug resistant microbes: E. coli, Candida, Salmonella, Shigella, enterococci, etc..

Chromogenic media are based on the principle of change in color of the chromophore, which is released when the bond between the substrate and chromophore is split by a specific enzyme produced by the target microorganism.

The chromophore forms a precipitate that imparts unique color to the colony. Chromogenic media also contain nutrients such as peptones, amino acids, yeast extract, minerals, vitamins, and solidifiers (agar). Depending on the purpose chromogenic media may also contain inhibitors.

Some of the advantages of using chromogenic media are:

• They are less labor intensive and more economic than traditional media, as they reduce the need for subculture and further biochemical tests for the identification of the isolates.
• They are less time consuming, as they provide results within 24 hours as compared to 48 hours or more by conventional methods.
• They are easy to identify, as target colonies of specific microorganisms can be recognized by their color at a glance.
• They do not require specialized equipment.

CHROMOGENIC MEDIA MARKET SIZE AND FORECAST

 The Global Chromogenic media market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

CHROMOGENIC MEDIA MARKETNEW PRODUCT LAUNCH

BioMérieux, a company that produces chromID™ media, which are chromogenic media for the detection and identification of clinically relevant bacteria and fungi, such as MRSA, VRE, C. difficile, Candida, etc.

Hardy Diagnostics, a company that produces HardyCHROM™ media, which are chromogenic media for the isolation and differentiation of urinary tract pathogens, Candida species, coliforms, Salmonella and Shigella, etc.

Merck, a company that produces GranuCult™ media, which are chromogenic media for the enumeration and identification of coliforms and E. coli in water and food samples

CHROMOGENIC MEDIA MARKETCOMPANY PROFILE

• CHROMagar
• BioMérieux
• Hardy Diagnostics
• Merck
• BioLegend

CHROMOGENIC MEDIA MARKETTHIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Chromogenic media are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Chromogenic media and key vendor selection criteria
3. Where is the Chromogenic media manufactured? What is the average margin per unit?
4. Market share of Global Chromogenic media market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Chromogenic media in-house
6. key predictions for next 5 years in Global Chromogenic media market
7. Average B-2-B Chromogenic media market price in all segments
8. Latest trends in Chromogenic media market, by every market segment
9. The market size (both volume and value) of the Chromogenic media market in 2024-2030 and every year in between?
10. Production breakup of Chromogenic media market, by suppliers and their OEM relationship